Skip to Content

Dasiglucagon Approval Status

FDA Approved: No
Generic name: dasiglucagon
Company: Zealand Pharma A/S
Treatment for: Hypoglycemia

HypoPal® Rescue Pen (dasiglucagon) is a glucagon analog in development for the treatment of severe hypoglycemia.

Development Status and FDA Approval Process for dasiglucagon

DateArticle
May 22, 2020Zealand Pharma Announces FDA acceptance of New Drug Application for the Dasiglucagon HypoPal® Rescue Pen for Treatment of Severe Hypoglycemia
Sep 24, 2019Zealand Pharma Achieves Primary and All Key Secondary Endpoints in Pediatric Phase 3 Trial with Dasiglucagon for Severe Hypoglycemia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.